Table 6.
Recell method | Cell source | Conditioning | Implant model | Details | Results |
---|---|---|---|---|---|
In vitro—chemical conditioning | rMSC,124 mMF,125 hMF,125 hEC125 | Valves coated with P3/4HB before seeding | None | Hybrid valves seeded in vitro | Hybrid valves had increased mechanics; in vitro seeding led to cell coverage, but no infiltration |
rMF,126 hECs,127,128 hMF129 | Leaflets modified with PEG plus TGF-β1, VEGF, or RGD peptides | None | PEG-peptide-modified leaflets seeded with cells | PEGylation increased mechanics and cell surface density, regardless of additional peptide; no cellular infiltration | |
gMSC130 | Encapsulation of cells in PEG before seeding | Goat aorta | PEG encapsulated cells seeded on decell scaffold and then implanted in goats | PEG cell seeding increased tensile strength, increased ratio of endothelial cells, and decreased thrombosis | |
rMSC,131 hEPC132,133 | Polyelectrolyte layers of heparin and SDF-1α/chitosan/VEGF adsorbed onto valve | None,132,133 rAorta131 | Valve scaffolds coated with polyelectrolyte multilayers and then seeded with cells | Treated valves led to reduced platelet activation; chitosan and VEGF increased EC adherence and proliferation in vitro; SDF-1α had increased endothelial layer after implant in vivo | |
oECs134 | Valves coated in CCN1 | oPV | Valves coated in CCN1 and before implant | Treated valves had good recell in vivo; cell coverage higher on ventricularis with mild infiltration of VIM+ and αSMA+ cells | |
rMSCs135 | Valves conjugated with CD90 antibody | None | Treated leaflets cultured in shear flow chamber with MSCs | Treated leaflets had increased cell attachment distributed across surface | |
pVIC,136 hMSC11 | Valves treated with fibronectin before seeding | None | Treated leaflets seeded statically | Leaflet surface coverage and mild cell infiltration by appropriate phenotypes | |
oECs137 | Valves treated with fibronectin before seeding | oPV | Treated valves seeded and then implanted | Treated valves had complete EC layer and good interstitial repopulation | |
hECs19–21 | Valve treated with ProNectin F before seeding | hPV | Treated valves seeded and implanted in 11 patients | 100% survival at 10 years 3 months biopsy of valve wall showed endothelialization and partial recell by fibroblast cells |
MSC: mesenchymal stem cell; MF: myofibroblast; EC: endothelial cell; P3/4HB: poly(3-hydroxybutyrate-co-4-hydroxybutyrate); PEG: polyethylene glycol; TGF-β1: transforming growth factor beta 1; VEGF: vascular endothelial growth factor; EPC: endothelial progenitor cell; SDF-1α: stromal cell–derived factor 1α; VIM: vimentin; αSMA: alpha-smooth muscle actin; VIC: valvular interstitial cell.
The results are overall observations and the outcome of individual studies may vary. Lower case letters in acronyms denote species (o = ovine, p = porcine, h = human, m = mouse, r = rat, g = goat).